During the past decade, Southern Endocrinology Associates conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 3 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Endocrinology Associates" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southern Endocrinology Associates" are "Obesity" (4 trials), "Overweight" (4 trials), "Type 2 Diabetes" (4 trials), "Diabetes" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Southern Endocrinology Associates" in a lesser frequency.

Most popular intervention types in "Southern Endocrinology Associates" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Insulin Degludec" (5 trials), "Tirzepatide" (5 trials), "Dulaglutide" (3 trials) and "Insulin Efsitora Alfa" (3 trials). Other intervention names were less common.

The vast majority of trials in "Southern Endocrinology Associates" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Southern Endocrinology Associates". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southern Endocrinology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Endocrinology Associates, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".